299 results on '"Fumagalli, Caterina"'
Search Results
2. Clinicopathological characteristics of multiple-classifier endometrial cancers: a cohort study and systematic review
3. Macrophage CD5L is a target for cancer immunotherapy
4. A novel algorithm to implement the molecular classification according to the new ESGO/ESTRO/ESP 2020 guidelines for endometrial cancer
5. CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas
6. Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations
7. Histopathological, Clinical, And Molecular (HICAM) score for patients with colorectal liver metastases
8. Temozolomide alone or in combination with capecitabine in patients with advanced neuroendocrine neoplasms: an Italian multicenter real-world analysis
9. P53-Abnormal Endometrial Cancer: To Be, Or Not To Be, That Is The Question
10. Understanding EGFR heterogeneity in lung cancer
11. Fibro-adipose vascular malformation (FAVA) in forearm: a successful surgical approach and literature review
12. Author Correction: A role for the immune system in advanced laryngeal cancer
13. Clinicopathological characteristics of multiple-classifier endometrial cancers: a cohort study and systematic review
14. Expanding the molecular landscape of undifferentiated sarcomas of bone with a novel EWSR1‐SSX3 gene fusion
15. Molecular testing in indeterminate thyroid nodules: an additional tool for clinical decision-making
16. A role for the immune system in advanced laryngeal cancer
17. Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses
18. Retiform Purpura After Percutaneous Angioplasty: Answer
19. Retiform Purpura After Percutaneous Angioplasty: Challenge
20. Expanding the molecular landscape of undifferentiated sarcomas of bone with a novel EWSR1‐SSX3 gene fusion.
21. Figure S2 from Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor–positive Early Breast Cancer: Results from the SOLE Trial
22. Table S1 from Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor–positive Early Breast Cancer: Results from the SOLE Trial
23. Supplementary Data from Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis
24. Data from Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis
25. Prevalence and Clinicopathologic Correlates of O6-Methylguanine-DNA Methyltransferase Methylation Status in Patients With Triple-Negative Breast Cancer Treated Preoperatively by Alkylating Drugs
26. Modified McCall culdoplasty versus Shull suspension in pelvic prolapse primary repair: a retrospective study
27. Cap-suction underwater endoscopic mucosal resection for en bloc resection of nongranular pseudodepressed colonic lesion: a novel technique when conventional snaring is not possible
28. 2022-RA-1289-ESGO Understanding clinical and pathological heterogeneity of endometrial cancer with no specific molecular profile (NSMP)
29. 2022-RA-659-ESGO The role of molecular classification in endometrial cancers with lymph nodes metastasis
30. 2022-RA-376-ESGO Clinicopathological characteristics of ‘multiple-classifiers’ in endometrial cancer
31. Nodal Merkel Cell Carcinoma with Unknown Primary Site and No Distant Metastasis: A Single-Center Series
32. In-house testing for homologous recombination repair deficiency (HRD) testing in ovarian carcinoma: a feasibility study comparing AmoyDx HRD Focus panel with Myriad myChoiceCDx assay
33. CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer
34. A novel algorithm to implement the molecular classification according to the new ESGO/ESTRO/ESP 2020 guidelines for endometrial cancer
35. Activity of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients with Non-small Cell Lung Cancer Harboring Rare Epidermal Growth Factor Receptor Mutations
36. The lymphoma-associated NPM-ALK oncogene elicits a p16INK4a/pRb-dependent tumor-suppressive pathway
37. Tumor BRCA Testing in Epithelial Ovarian Cancers: Past and Future—Five-Years’ Single-Institution Experience of 762 Consecutive Patients
38. Abstract P1-22-03: Expression of immune-related genes and breast cancer recurrence in women with ductal carcinoma in situ
39. Immunotherapy in Breast Cancer Patients: A Focus on the Use of the Currently Available Biomarkers in Oncology
40. HotspotESR1Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis
41. Sarcomatoid transformation of a basal cell carcinoma following treatment with hedgehog inhibitors.
42. Methylation of O 6-methylguanine-DNA methyltransferase (MGMT) promoter gene in triple-negative breast cancer patients
43. Pathologic and molecular features of screening low-dose computed tomography (LDCT)-detected lung cancer: A baseline and 2-year repeat study
44. Breast Cancer Heterogeneity
45. The accuracy of p53 immunohistochemistry is impaired in endometrial cancer with a high mutation burden (1256)
46. Genomic aberrations and late recurrence in postmenopausal women with hormone receptor⇓positive early breast cancer: results from the SOLE trial
47. Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations
48. Diagnostic and Predictive Biomarkers in Lung Cancer
49. Genomic Characterization of Concurrent Alterations in Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Mutations
50. A systematic review and meta‐analysis of the prognostic role of age in oral tongue cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.